Author

Jacob G. Thomas

Observed names: J Thomas, J. Thomas

Institution: University of Toronto

Observed institutions: Mayo Clinic, University of Wisconsin–Madison, Johns Hopkins University, University of Toronto, The Barbara Ann Karmanos Cancer Institute, Mayo Clinic in Arizona

OpenAlex ID: A5090843397

CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.

1998 · J Lundin, A Osterborg, et al. · Journal of Clinical Oncology · 255

Phase II Trial of erlotinib (OSI-774) in patients with hepatocellular or biliary cancer

2004 · P. A. Philip, M. Mahoney, et al. · Journal of Clinical Oncology · 26

Medication-related osteonecrosis of the jaw: a narrative review of risk factors, diagnosis, and management

2022 · Jacob G. Thomas, Aviv Ouanounou · Frontiers of Oral and Maxillofacial Medicine · 21

Chronic Thrombotic Microangiopathy Secondary to Chemotherapy for Urothelial Carcinoma in a Patient With a History of Wegener Granulomatosis

2011 · Jacob G. Thomas, Sanjeev Sethi, et al. · American Journal of Kidney Diseases · 12

Weekly low-dose doxorubicin in advanced breast cancer.

1986 · P Specenier, J Thomas · PubMed · 9

In Reply to ‘Development of Thrombotic Microangiopathy in a Patient With Granulomatosis With Polyangiitis’

2011 · Suzanne M. Norby, Jacob G. Thomas, et al. · American Journal of Kidney Diseases

Prolonged prednisolone therapy in adult nephrotic syndrome: a preliminary study.

1988 · A Akinsola, A O Iyun, et al. · PubMed

Works count: 7

Citation count: 322

H-index: 5

I10-index: 4